{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:37:52Z","timestamp":1780637872488,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113818","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T02:12:43Z","timestamp":1734228763000},"page":"113818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Artemisitene ameliorates carbon tetrachloride-induced liver fibrosis by inhibiting NLRP3 inflammasome activation and modulating immune responses"],"prefix":"10.1016","volume":"146","author":[{"given":"Meng-Ke","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Juan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ling","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan-Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Jin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1358-6421","authenticated-orcid":false,"given":"Zi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2024.113818_b0005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"26","key":"10.1016\/j.intimp.2024.113818_b0010","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1021\/jm0103007","article-title":"C-16 artemisinin derivatives and their antimalarial and cytotoxic activities: syntheses of artemisinin monomers, dimers, trimers, and tetramers by nucleophilic additions to artemisitene","volume":"44","author":"Ekthawatchai","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.113818_b0015","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway","volume":"109","author":"Kong","year":"2019","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"issue":"2","key":"10.1016\/j.intimp.2024.113818_b0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.apsb.2020.09.001","article-title":"Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics","volume":"11","author":"Dolivo","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.113818_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","article-title":"Artemisinins and immune system","volume":"668","author":"Shakir","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113818_b0030","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1096\/fj.201500109R","article-title":"Artemisitene activates the Nrf2-dependent antioxidant response and protects against bleomycin-induced lung injury","volume":"30","author":"Chen","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2024.113818_b0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejphar.2015.08.040","article-title":"Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS\/TLR4\/NF-\u03baB signaling pathway in rats","volume":"765","author":"Lai","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113818_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2014.09.035","article-title":"Artesunate ameliorates hepatic fibrosis induced by bovine serum albumin in rats through regulating matrix metalloproteinases","volume":"744","author":"Xu","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113818_b0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/biof.1764","article-title":"Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells","volume":"47","author":"Zhang","year":"2021","journal-title":"BioFactors (oxford, England)"},{"issue":"6","key":"10.1016\/j.intimp.2024.113818_b0050","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1002\/med.21842","article-title":"The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases","volume":"41","author":"Efferth","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2024.113818_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9202128","article-title":"Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k\/AKT Pathway","volume":"2022","author":"Cheng","year":"2022","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2024.113818_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104829","article-title":"Novel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis","volume":"157","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"sup3","key":"10.1016\/j.intimp.2024.113818_b0065","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.1080\/21691401.2018.1505739","article-title":"Progress in nano-drug delivery of artemisinin and its derivatives: towards to use in immunomodulatory approaches","volume":"46","author":"Charlie-Silva","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113818_b0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-2007-969543","article-title":"Artemisitene, a New Sesquiterpene Lactone Endoperoxide from Artemisia annua","volume":"51","author":"Acton","year":"1985","journal-title":"Planta Med."},{"issue":"37","key":"10.1016\/j.intimp.2024.113818_b0075","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1038\/s41388-018-0331-z","article-title":"Artemisitene suppresses tumorigenesis by inducing DNA damage through deregulating c-Myc-topoisomerase pathway","volume":"37","author":"Chen","year":"2018","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.intimp.2024.113818_b0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/rcm.7881","article-title":"Determination of artemisitene in rat plasma by ultra-performance liquid chromatography\/tandem mass spectrometry and its application in pharmacokinetics","volume":"31","author":"Wu","year":"2017","journal-title":"Rapid Communications in Mass Spectrometry : RCM"},{"key":"10.1016\/j.intimp.2024.113818_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1221291","article-title":"Artemisitene: a promising natural drug candidate with various biological activities needs to confirm the interactional targets","volume":"14","author":"Lin","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113818_b0090","article-title":"Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis","volume":"113","author":"Hua","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113818_b0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/cyto.a.24702","article-title":"OMIP-086: Full spectrum flow cytometry for high-dimensional immunophenotyping of mouse innate lymphoid cells","volume":"103","author":"Mincham","year":"2023","journal-title":"Cytometry A"},{"key":"10.1016\/j.intimp.2024.113818_b0100","first-page":"8","article-title":"Positive Feedback Regulation between Transglutaminase 2 and Toll-Like Receptor 4 Signaling in Hepatic Stellate Cells Correlates with Liver Fibrosis Post Schistosoma japonicum Infection","volume":"2017","author":"Wen","year":"1808","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2024.113818_b0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.intimp.2016.03.011","article-title":"Dihydroartemisinin alleviates bile duct ligation-induced liver fibrosis and hepatic stellate cell activation by interfering with the PDGF-\u03b2R\/ERK signaling pathway","volume":"34","author":"Chen","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113818_b0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.freeradbiomed.2016.10.498","article-title":"ROS-JNK1\/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis","volume":"101","author":"Zhang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.intimp.2024.113818_b0115","article-title":"Artemisitene Alters LPS-Induced Oxidative stress, inflammation and Ferroptosis in Liver Through Nrf2\/HO-1 and NF-kB Pathway","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113818_b0120","doi-asserted-by":"crossref","first-page":"e1148","DOI":"10.1002\/ctm2.1148","article-title":"Artemisitene suppresses rheumatoid arthritis progression via modulating METTL3-mediated N6-methyladenosine modification of ICAM2mRNA in fibroblast-like synoviocytes","volume":"12","author":"Chen","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113818_b0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s13071-024-06426-y","article-title":"Artemisitene shows superiority over artemisinin in preventing Schistosoma japonica-induced liver disease","volume":"17","author":"Liu","year":"2024","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.intimp.2024.113818_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133543","article-title":"Revealing immune infiltrate characteristics and potential immune-related genes in hepatic fibrosis: based on bioinformatics, transcriptomics and q-PCR experiments","volume":"14","author":"Bai","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113818_b0135","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1002\/mco2.654","volume":"5","author":"Chen","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.intimp.2024.113818_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120235","article-title":"Targeting cIAPs attenuates CCl(4)-induced liver fibrosis by increasing MMP9 expression derived from neutrophils","volume":"289","author":"Wu","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.113818_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1277808","article-title":"Macrophages and platelets in liver fibrosis and hepatocellular carcinoma","volume":"14","author":"Casari","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113818_b0150","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"T Cells in Fibrosis and Fibrotic Diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113818_b0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113818_b0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2013.07.018","article-title":"Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis","volume":"39","author":"McHedlidze","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2024.113818_b0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/cmi.2016.62","article-title":"Interleukin-33 in the pathogenesis of liver fibrosis: alarming ILC2 and hepatic stellate cells","volume":"14","author":"Weiskirchen","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.113818_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9591544","article-title":"New Insights into Artesunate as a Pleiotropic Regulator of Innate and Adaptive Immune Cells","volume":"2022","author":"Lin","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.113818_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.06.016","article-title":"Inflammasomes in chronic liver disease: hepatic injury, fibrosis progression and systemic inflammation","author":"Taru","year":"2024","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113818_b0180","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jcmgh.2022.06.007","article-title":"Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis","volume":"14","author":"Kaufmann","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113818_b0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113818_b0190","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s41423-018-0054-7","article-title":"IL-1 \u03b2 genesis: the art of regulating the regulator","volume":"15","author":"Gupta","year":"2018","journal-title":"Cell. Mol. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924023403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:48:57Z","timestamp":1736614137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924023403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S1567576924023403"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113818","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artemisitene ameliorates carbon tetrachloride-induced liver fibrosis by inhibiting NLRP3 inflammasome activation and modulating immune responses","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113818"}}